Physiologically Based Pharmacokinetic Modelling to Identify Pharmacokinetic Parameters Driving Drug Exposure Changes in the Elderly-Reference-Cited by-同舟云学术

Physiologically Based Pharmacokinetic Modelling to Identify Pharmacokinetic Parameters Driving Drug Exposure Changes in the Elderly

Published:2019-10-04 Issue:3 Volume:59 Page:383-401
ISSN:0312-5963
Container-title:Clinical Pharmacokinetics
language:en
Short-container-title:Clin Pharmacokinet

Author:

Stader Felix^ORCID,Kinvig Hannah,Penny Melissa A.,Battegay Manuel,Siccardi Marco,Marzolini Catia

Funder

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s40262-019-00822-9.pdf

Reference74 articles.

1. Ortman JM, Velkoff VA, Hogan H. An aging nation: the older population in the United States. Washington, DC: United States Census Bureau, Economics and Statistics Administration; 2014.

2. European Union—Eurostats. People in the EU—population projections; 2017. https://ec.europa.eu/eurostat/statistics-explained/index.php/People_in_the_EU_-_population_projections#Age_dependency_ratios . Cited 6 Feb 2019.

3. Jaul E, Barron J. Age-related diseases and clinical and public health implications for the 85 years old and over population. Front Public Health. 2017;5:335–41.

4. Eurostat. Medicine use statistics; 2014. https://ec.europa.eu/eurostat/statistics-explained/index.php/Medicine_use_statistics . Cited 15 Nov 2018.

5. US Food and Drug Administration. Diversity in clinical trials; 2018. Available at: https://www.fda.gov/ForConsumers/ConsumerUpdates/ucm535306.htm . Cited 15 Nov 2018.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utility of life stage-specific chemical risk assessments based on New Approach Methodologies (NAMs);Food and Chemical Toxicology;2024-08

2. Ageing-related considerations for medication used in supportive care in cancer;Journal of Geriatric Oncology;2024-06

3. Central Nervous System Medications: Pharmacokinetic and Pharmacodynamic Considerations for Older Adults;Drugs & Aging;2024-05-30

4. Evaluation of Age-Related Changes in Teneligliptin Pharmacokinetics in Japanese and European Descent Subjects Using a Physiologically Based Pharmacokinetic Model;Diabetes Therapy;2023-12-20

5. Physiologically based pharmacokinetic modeling of apixaban to predict exposure in populations with hepatic and renal impairment and elderly populations;European Journal of Clinical Pharmacology;2023-12-15